Common adverse effects include nausea, vomiting, diarrhoea, constipation, and abdominal discomfort, particularly during the dose-escalation phase
The development of newer obesity treatments represents the achievement of a long-standing goal of medical research, but prices of these new products must be reasonable to allow broad access to them, he noted
Safety concerns include common gastrointestinal side effects, such as nausea and vomiting, as well as potential risks related to the pancreas, gallbladder, and thyroid C-cell tumors
Case Growth: By mid-2025, over 10,000 cases were part of the MDL
New insights into dietary approaches to potassium management in chronic kidney disease